## CI: The Cigna Group - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.55 indicates fundamental undervaluation. Quality metrics strong (ROE 16%). Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($263.04)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. CI STOCK ALERT: Levi & Korsinsky Notifies The Cigna Group Investors of an Ongoing Investigation**
- Source: ACCESS Newswire | 20251215T140756 | Bearish | Relevance: 100%
- Levi & Korsinsky has launched an investigation into The Cigna Group (NYSE:CI) for potential federal securities law violations. This investigation follows CI's third-quarter 2025 earnings report, which revealed an increase in their Healthcare MCR to 84.8% from 82.8% in 2024, attributed to their Individual and Family Plans business and higher stop loss medical costs. This news led to a 17% drop in CI's stock price on October 30, 2025.

**2. Rep. Julie Johnson Sells Off Shares of Merck & Co., Inc. (NYSE:MRK)**
- Source: MarketBeat | 20251215T102441 | Somewhat-Bearish | Relevance: 75%
- Representative Julie Johnson (D-Texas) sold between $1,001 and $15,000 of Merck & Co., Inc. (NYSE:MRK) stock on November 13th, a transaction disclosed on December 11th. This was part of a series of similar sales she made in several large companies including Charles Schwab, UnitedHealth, and Goldman Sachs on the same day. Merck recently reported strong quarterly earnings, setting positive FY2025 guidance and increasing its quarterly dividend.

**3. Rep. Julie Johnson Sells Off Shares of The Home Depot, Inc. (NYSE:HD)**
- Source: MarketBeat | 20251215T130841 | Neutral | Relevance: 75%
- Representative Julie Johnson (D-Texas) recently sold shares of The Home Depot, Inc. (NYSE: HD) valued between $1,001 and $15,000 on November 13th, as disclosed in a December 11th filing. This sale was part of similar-sized transactions involving ten other major stocks on the same day. Home Depot recently missed quarterly EPS expectations but reported revenue growth, set FY2025 guidance, and announced a quarterly dividend, while analysts maintain a "Moderate Buy" rating with a target price of $401.17.

**4. Rep. Julie Johnson Sells Off Shares of PepsiCo, Inc. (NASDAQ:PEP)**
- Source: MarketBeat | 20251215T102448 | Somewhat-Bearish | Relevance: 73%
- Representative Julie Johnson (D-Texas) recently sold between $1,001 and $15,000 worth of PepsiCo (NASDAQ:PEP) stock, along with similar amounts of other major company stocks, on November 13, 2025. PepsiCo is trading near $150.65, with analysts maintaining a "Hold" rating and a target price of $158.35. The company recently declared a quarterly dividend of $1.4225, representing a 3.8% yield.

**5. Rep. Julie Johnson Sells Philip Morris International Inc. (NYSE:PM) Shares**
- Source: MarketBeat | 20251215T132136 | Neutral | Relevance: 73%
- Representative Julie Johnson (D-Texas) recently sold between $1,001 and $15,000 worth of Philip Morris International Inc. (NYSE:PM) shares on November 13th, as disclosed in a December 11th filing. She also sold similar amounts of shares in several other major companies on the same date. The article provides a financial overview of Philip Morris International, including its market performance, recent earnings, dividend announcement, and institutional investor activity, alongside analyst ratings.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($1.01M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+0.1%)
- Blackrock Inc.: 8.3% (-1.1%)
- JPMORGAN CHASE & CO: 5.0% (+106.4%)
- State Street Corpora: 4.5% (-1.2%)
- Price (T.Rowe) Assoc: 4.2% (+9.8%)

### Key Risks

1. Long-term trend broken: trading 8.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +7.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.55 indicates undervaluation relative to growth. Forward P/E 9.0x stretched relative to 3% growth. Balance sheet: $3.1B free cash flow. Insider buying signal ($1.0M), management confidence. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $73.8B |
| Beta | 0.26 |
| 52W Range | $239.51 - $350.00 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.55 |
| Forward P/E | 9.0 |
| Current P/E | 9.3 |
| YoY Growth | 3.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -5.1% to 1.9% (+7.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.1pp (needs >4.0% for momentum thesis). MRS_5 at 2.2% confirms short-term momentum alignment. Below SMA200 (0.91x), long-term trend not supportive. MACD histogram positive (1.34), confirming momentum. RSI neutral at 53. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.88% (CS: 59) | Neutral |
| RSI_14 | 53.2 | Neutral |
| MACD Histogram | 1.34 | Bullish |
| vs SMA20 | 1.015x | Above |
| vs SMA50 | 0.986x | Below |
| vs SMA200 | 0.913x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $275.98
- **Stop Loss:** $263.04 (4.7% risk)
- **Target:** $301.86 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $21,250.46
- **Portfolio %:** 21.25%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-05 (Est: $7.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.64 | $7.83 | +2.5% |
| 2025Q2 | $7.15 | $7.20 | +0.6% |
| 2025Q1 | $6.35 | $6.74 | +6.2% |
| 2024Q4 | $7.82 | $6.64 | -15.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*